No disease-specific neuronal antibodies have so far been defined in neuro-Behçet's disease (NBD). Immunohistochemistry and immunocytochemistry studies showed antibodies to hippocampal and cerebellar molecular layers and the surface antigens of cultured hippocampal neurons in sera and/or cerebrospinal fluids (CSF) of 13 of 20 NBD and 6 of 20 BD patients but not in multiple sclerosis or headache controls. Screening with a protein macroarray led to identification of stress-induced-phosphoprotein-1 (STIP-1) as an antigenic target. High-titer STIP-1-antibodies were detected in 6 NBD patients' sera but not in controls. These results suggest that neuronal antibodies could be useful as diagnostic biomarkers in NBD.
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Introduction
Behçet's disease (BD) is a chronic, recurrent and inflammatory disorder characterized with oral and genital aphthous ulcerations, uveitis, skin lesions and skin pathergy reaction. Several tissues such as blood vessels, eyes, skin, joints, lungs and brain may be affected during the course of this disease. The involved tissues generally show a nonspecific mononuclear and neutrophilic inflammatory reaction (Gül, 2005; Yurdakul and Yazici, 2008) . Although the etiology of BD remains unknown, the presence of inflammatory lesions and identification of antibodies directed against antigens shared between microorganisms and the involved tissues of the patients [e.g. heat shock proteins (HSPs)] have suggested an autoimmune nature (Lehner et al., 1991) but efforts to demonstrate autoantibodies that are highly sensitive and specific to BD have so far failed.
The central nervous system (CNS) involvement, named as neuroBehçet's disease (NBD), develops in 5-10% of BD patients and generally afflicts the brain parenchyma and less frequently the brain vessels and meninges (Akman-Demir et al., 1999) . In an attempt to identify disease and tissue specific (i.e. anti-neuronal) antibodies, serum and cerebrospinal fluid (CSF) samples of NBD patients and controls were screened using immunohistochemistry, immunocytochemistry and protein macroarray and the results were compared with demographic and clinical features of the patients.
Materials and methods

Patients and samples
Twenty consecutive NBD patients (9 women, 11 men; mean age ± standard deviation, 43.6 ± 12.1), who were followed in our outpatient clinic and whose serum and CSF samples were available were included. The average NBD duration of these patients was 9.1 ± 5.1 years. Controls included twenty age-and gender-matched BD patients with primary headache disorders without neurological involvement (BD), (10 women, 10 men; mean age ± standard deviation, 43.1 ± 10.4), 20 with multiple sclerosis (MS) (11 women, 9 men; mean age ± standard deviation, 41.9 ± 11.7) and 20 with primary headache disorders only (10 women, 10 men; mean age ± standard deviation, 42.5 ± 9.2). E-mail address: drerdem@yahoo.com (E. Tüzün).
